Phase I trial of the combination of the Akt inhibitor nelfinavir and chemoradiation for locally advanced rectal cancer

J. Buijsen*, G. Lammering, R.L. Jansen, G.L. Beets, J. Wals, M. Sosef, M.O. Den Boer, J. Leijtens, R.G. Riedl, J. Theys, P. Lambin

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

36 Citations (Web of Science)
5 Downloads (Pure)
Original languageEnglish
Pages (from-to)184-188
Number of pages5
JournalRadiotherapy and Oncology
Volume107
Issue number2
DOIs
Publication statusPublished - May 2013

Keywords

  • Rectal cancer
  • Chemoradiation
  • Phase I
  • Nelfinavir
  • HIV PROTEASE INHIBITOR
  • PREOPERATIVE RADIATION
  • COLORECTAL-CANCER
  • MANAGEMENT
  • MUTATIONS
  • PATHWAY
  • CELLS
  • VIVO
  • CHEMORADIOTHERAPY
  • INDINAVIR

Cite this